Oasmia Pharmaceutical (OASM) Priced

Developing formulations of widely-used cancer drugs for humans and dogs.

Health Care - Biotechnology

IPO Performance
Latest Trade $2.30 0.00 (0.0%)
First Day Return -3.9%
Return from IPO -43.3%
 
Oasmia Pharmaceutical IPO News more
  • .
IPO Data
IPO File Date 07/06/2015
Offer Price $4.06
Price Range $4.70 - $6.70
Offer Shares (mm) 2.3
Deal Size ($mm) 9
 
IPO Data
IPO Date 10/22/2015
Offer Price $4.06
Price Range $4.70 - $6.70
Offer Shares (mm) 2.3
Deal Size ($mm) $9
 
Underwriters
more
Business Overview
Developing formulations of widely-used cancer drugs for humans and dogs.
Developing formulations of widely-used cancer drugs for humans and dogs.
more
Company Data
Headquarters Uppsala, , Sweden
Founded 1999
Employees 80
Website www.oasmia.com
 

Performance vs. IPO Index (IPOUSA)